Logo image of ADMS

Adamas Pharmaceuticals Inc (ADMS) Stock News

NASDAQ:ADMS - Nasdaq - Common Stock

8.22  +0.06 (+0.74%)

After market: 8.3 +0.08 (+0.97%)

ADMS Latest News, Press Relases and Analysis

News Image
10 months ago - Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMS

/PRNewswire/ -- Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of California has approved the following...

News Image
3 years ago - Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021

  Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:

Mentions: TX AMWD TRIL CMC ...

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP is Investigating the Following Companies - BCML, GWB, ABTX, ESBK, ADMS, ACBI

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: BayCom Corp (NASDAQ: BCML)...

Mentions: BCML GWB ABTX ESBK ...

News Image
3 years ago - WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, ADMS, and ACBI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

Mentions: DWSN PAE ACBI

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ROG, RRD, XLRN, ADMS; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rogers Corporation (NYSE: ROG)...

Mentions: ROG RRD GWB XLRN

News Image
3 years ago - WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Reminds OMP, ADMS, ACBI and ECHO Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

Mentions: OMP ACBI ECHO

News Image
3 years ago - Zacks Investment Research

Will Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should Know

Adamas (ADMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: FTS International, Inc. (NYSE:...

Mentions: FTSI UMPQ FLXN

News Image
3 years ago - WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

Mentions: FLXN AZPN EBMT

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, XLRN, ADMS, AZPN; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / October 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Umpqua Holdings Corporation (NASDAQ:UMPQ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Columbia Banking System, Inc. Under the terms of the agreement, Umpqua shareholders will receive 0.5958 of a share of Columbia

Mentions: UMPQ XLRN AZPN

News Image
3 years ago - The Motley Fool

Why Supernus' Acquisition of Adamas Is a Smart Move

Adamas looks like a good fit for Supernus.

Mentions: SUPN

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRA, EBMT, ESBK, ADMS; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kraton Corporation (NYSE: KRA)...

Mentions: KRA EBMT ESBK

News Image
3 years ago - WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

Mentions: FLXN AZPN EBMT

News Image
3 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, ACBI, SQ; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Adamas Pharmaceuticals, Inc....

Mentions: FLXN ACBI SQ

News Image
3 years ago - Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021

Upgrades For Callaway Golf Co (NYSE:ELY), Compass ...

Mentions: ZH AMKR NKE DKNG ...

News Image
3 years ago - WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Investigates Adamas Pharmaceuticals, Inc.

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Adamas...

Mentions: SUPN

News Image
3 years ago - Invezz

Supernus Pharmaceuticals to acquire this Pharmaceuticals company for $400 million

Merck is seeking the FDA's permission for emergency use of its experimental antiviral drug in treating COVID-19.

Mentions: SUPN

News Image
3 years ago - Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Adamas Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Supernus

/PRNewswire/ -- Ademi LLP is investigating Adamas (Nasdaq: ADMS), for possible breaches of fiduciary duty and other violations of law in its transaction with...

News Image
3 years ago - InvestorPlace

ADMS Stock Soars 70% Thanks to Adamas Pharmaceuticals Acquisition News

ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth $400 million.

Mentions: SUPN

News Image
3 years ago - Adamas Pharmaceuticals, Inc.

Adamas Announces New Employment Inducement Grants

News Image
3 years ago - Adamas Pharmaceuticals, Inc.

Adamas Announces New Employment Inducement Grants